This is a membership services update featuring OPRx partner, Diplomat Specialty Pharmacy.  Diplomat is part of a limited number of pharmacies to have access to Zytiga.

  

The FDA approves Zytiga (abiraterone acetate) in combination with Prednisone for the treatment of men with castration-resistant prostate cancer (prostate cancer that is resistant to medical or surgical treatments that lower testosterone) that has spread to other parts of the body and who have received treatment with Taxotere (docetaxel).